Portfolio
Notion Systems
Notion Systems GmbH develops, produces and markets inkjet, laser and automation equipment for applications in photovoltaics, printed electronics, printed circuit board and other industries. A cost effective platform concept, precise positioning solutions, a large choice of automation solutions and industrial strength sets Notion Systems products apart from those of competitors. It supports its customers with the comprehensive knowledge of processes in the photovoltaics, printed electronics and p
Portfolio
userlane
Key to Userlaneâs technology are interactive step-by-step guides, which can be implemented on top of every existing web-based software or e-commerce website. These interactive guides lead every user through all processes and show them real-time where to click next within the software â just like GPS navigation systems in cars advice drivers turn-by-turn how to optimally reach the destination. This way complex software can be easily used, without previous knowledge, making extensive software
Portfolio
gravit
Gravit GmbH was founded in November 2015 in Berlin. Gravit develops an innovative web-based design software (Gravit Designer) that allows everyone to create effortlessly all kinds of professional design, including web and screen design, mobile design, logos, flyers, business cards and more.
Gravit Designer is completely based on HTML5, CSS and JavaScript, which allows it to run smoothly in any modern browser and operating system. The unique technology behind Gravit allows designs to be stored an
Portfolio
Alentis
Alentis Therapeutics discovers and develops novel medications to treat advanced liver diseases, such as liver fibrosis, cirrhosis and liver cancer (hepatocellular carcinoma, HCC).
Alentis has in-licensed platform technologies and monoclonal antibodies which are the result of more than a decade of research from the University of Strasbourg and Inserm, the French National Institutes of Health and the Mount Sinai Hospital, New York.
The portfolio is based on profound knowledge and expertise in live
Portfolio
DeepScenario
DeepScenario is an AI start-up that provides the worldâs leading platform for training, testing, and validating autonomous systems of any kind, with a particular focus on the automotive industry. The company traces its roots to cutting-edge research in computer vision, autonomous systems, and artificial intelligence spanning multiple man-years. The team at DeepScenario combines scientific domain knowledge, industrial usage knowledge, and a passion for innovation and entrepreneurship to help cu
Press
Altavo completes Seed Financing Round for the Development of AI-based Voice Prosthetics
Altavo GmbH, a speech technology and medical technology spin-off of TU Dresden, successfully completed its seed financing round in December 2021. A consortium led by High-Tech GrĂźnderfonds (HTGF) is investing in the development of Altavoâs AI-based speech prosthesis.
Altavo is developing a non-invasive prosthesis aimed at restoring an individual, natural-sounding voice for people who have lost their voice, for example, due to laryngectomy. The approach is based on non-invasive radar se
Press
JeNaCell Receives Seed Financing from High-Tech GrĂźnderfonds and STIFT
High-Tech GrĂźnderfonds and STIFT are jointly investing âŹ700,000 in JeNaCell GmbH. The capital will be used to build up automated production in the creation of a high-performance, high-tech biomaterial.
The business idea of JeNaCell GmbH, a spin-off of the Friedrich Schiller University in Jena, Germany, is based on a new and patented process for the continuous production of a high-performance biomaterial with natural nanostructures, which can be used for making innovative medical and cosmet
Press
Cybersecurity pioneer VMRay extends Series B investment to a total of $34 million USD to drive growth into new markets
VMRay, a global player in advanced threat detection and analysis that offers solutions for enterprises, governmental organizations, and MDRs to detect and analyze the most challenging malware and phishing threats, announces the closing of a Series B led by global alternative asset manager Tikehau Capital, through its subsidiary Tikehau Ace Capital and its European Cybersecurity Growth fund alongside new investors NRW.BANK and GrĂźnderfonds Ruhr. Previous investors eCAPITAL and High-Tech GrĂź
Press
BORN2GROW supports biotech start-up Venneos with its further growth
Venture capital fund BORN2GROW has invested in Stuttgart-based Venneos GmbH in the current round of series A financing. The start-up is successfully developing and marketing the CAN-Q â a silicon chip-based imaging system for analysing biological cells.
âWe are thrilled to have BORN2GROW on-board as a new investor, and that we will be able to benefit from its extensive expertise in the field of life sciences,â says David Wehner, one of the co-founders and co-directors of Venneos GmbH.
Press
Innovative measurement for geothermal probes and industrial applications
HTGF, LBBW Venture and KIC InnoEnergy invest in enOware GmbH
Operators of near-surface geothermal probes can get up-to-the-minute relevant system data with GEOsniff and an app. GEOsniff is a wireless, miniaturized measuring capsule, the first product developed by Karlsruhe startup enOware.
The measuring capsule delivers data in real time, creates transparency, and helps with optimum monitoring of existing and new geothermal systems. As part of seed financing, the High-Tech GrĂźnderfonds, LB
Start-up financing
More Than Capital
HTGF is a seed investor for innovative technologies and business models. We are successful in supporting the best founders whose ideas can revolutionize entire industries and improve peopleâs lives â from the foundation of a start-up to its exit.
Miriam Haerst
Co-Founder / Managing Partner Kumovis GmbH
Press
HTGF, BayernKapital and a business angel consortium invest in ADVANOVA GmbH
ADVANOVA GmbH has successfully concluded its first round of financing. High Tech Gruenderfonds (HTGF), BayernKapital and a consortium of business angels are investing in the further development and marketing of the first mobile, electronic patient chart for use in hospitals.
"In addition to working to further develop our VMobil software, we are paying particular attention to marketing this successfully,â states Bastian Bleisinger, Managing Director and Founder of ADVANOVA. âThis investmen
Event
Kickstart International Program
“Kickstart International” offers a new opportunity for founders to prepare for international expansion at an early stage and to acquire the necessary knowledge and tools. Free program, run by German Accelerator.
German Accelerator supports German startups with high potential in successfully entering the US and Asian markets.
Program participants are also supported in making critical decisions when it comes to business model and products and get prepared for a siginificant growth in t
Blog
What have you learnt? Episode 3 with Lymphaticas Valentina Triacca
What have you learnt? This is a question we’re putting to company founders from our portfolio. Because if you found a start-up, run a company, make investments or work in management, you are learning something new every single day. You also have to deal with new situations. And continue to develop new skills. To cover the latter aspect, we expanded the HTGF Academy this year to offer a comprehensive programme for company founders. And because we firmly believe in the power of peer-to-p
Press
Alentis Therapeutics closes $105 million Series C funding to advance transformational medicines for Claudin-1
Proceeds will fund:
Clinical programs ALE.F02 and ALE.C04 â two first-in-class anti-Claudin-1Â (CLDN1) antibodies for organ fibrosis and CLDN1 positive tumors
The platform to engineer CLDN1 antibody drug conjugates (ADC) and bispecific antibodies
Basel, Switzerland â 13 April 2023, Alentis Therapeutics (âAlentisâ), the Claudin-1 (CLDN1) company, is a clinical-stage biotech company developing breakthrough treatments for organ fibrosis and CLDN1 positive tumors. Today, A
Press
High Tech Gruenderfonds Invests in NovaPump GmbH
The Jena-based heart technology firm NovaPump GmbH has successfully completed a first round of financing with High Tech Gruenderfonds in July 2013. This financing will support the development of a catheter-based procedure for right heart and biventricular support.
The basic concept being developed by the team working with NovaPump founder and cardiologist Dr. Markus Ferrari and Managing Director Ronald Reich (M.Eng.) offers significant advantages over the current state of technology. NovaPump